These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 318115)

  • 1. [Levamisole as an immunostimulating factor].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1979; 8():56-62. PubMed ID: 318115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunopharmacology of levamisole].
    Symoens J
    Z Hautkr; 1979 May; 54(9):394-402. PubMed ID: 375604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [E-RFC (T cells) and Ig-positive cells (B cells) in the peripheral blood of patients with lymphogranulomatosis and possible immunocorrection with levamisole].
    Markova TP; Danilova NV
    Ter Arkh; 1985; 57(7):15-8. PubMed ID: 3876611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term therapy with sulphasalazine, levamisole, corticosteroids and ascorbic acid and of disease activity on polymorphonuclear leukocyte function in patients with ulcerative colitis.
    Hermanowicz A; Sliwiński Z; Kaczor R
    Hepatogastroenterology; 1985 Apr; 32(2):81-6. PubMed ID: 2861152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the chemotactic response of bovine polymorphonuclear leukocytes by levamisole.
    Jayappa HG; Loken KI
    Am J Vet Res; 1982 Dec; 43(12):2138-42. PubMed ID: 6762119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole in the treatment of Hodgkin's disease.
    Berényi E; Kávai M; Szabolcsi M; Szegedi G
    Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotactic function of polymorphonuclear leukocytes from patients with recurrent infections: partial correction by levamisole "in vitro".
    Stein AN; Díez RA; Sen L; Estévez ME
    Allergol Immunopathol (Madr); 1985; 13(2):127-34. PubMed ID: 4003229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of levamisole on normal and abnormal leukocyte locomotion.
    Wright DG; Kirkpatrick CH; Gallin JI
    J Clin Invest; 1977 May; 59(5):941-50. PubMed ID: 192765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro reversal of cellular unresponsiveness induced by levamisole.
    Golding H; Golding B; Jacobson R; Lomnitzer R; Koornhof HJ; Rabson AR
    Clin Exp Immunol; 1976 Nov; 26(2):295-301. PubMed ID: 791550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
    Bonventre PF; Straus D; Baughn RE; Imhoff J
    J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective neutrophil motility and recurrent infection. In vitro and in vivo effects of levamisole.
    Rabson AR; Anderson R; Glover A
    Clin Exp Immunol; 1978 Jul; 33(1):142-9. PubMed ID: 709909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of orally administered levamisole on random monocyte motility and chemotaxis in man.
    Nathanson SD; Zamfirescu PL; Portaro JK; deKernion JB; Fahey JL
    J Natl Cancer Inst; 1978 Aug; 61(2):301-6. PubMed ID: 355647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil function in surgical patients: in vitro correlation of abnormal neutrophil chemotaxis by Levamisole.
    Christou NV; Meakins JL
    Surgery; 1979 May; 85(5):543-8. PubMed ID: 432816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy.
    Urist MM; Boddie AW; Townsend CM; Holmes EC
    J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fatal granulocyte function defect in a male infant. Results of in vitro and in vivo stimulation with ascorbic acid as well as in vitro stimulation with levamisol and lithium chloride].
    Dopfer R; Döring A; Neef V; Kollmann W; Niethammer D
    Monatsschr Kinderheilkd; 1982 Dec; 130(12):891-5. PubMed ID: 6296667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of levamisole on nonspecific resistance of patients in the early post-shock period].
    Khudaĭberenov GS; Seleznev SA; Podosinnikov IS; Pivovarova LP; Nilova LG
    Vestn Khir Im I I Grek; 1986 May; 136(5):93-8. PubMed ID: 3750693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of immunologic deficiency and its correction in suppurative infection of the abdominal cavity].
    Briskin BS; Savchenko ZI; Khachatrian NN
    Klin Med (Mosk); 1989 Oct; 67(10):128-32. PubMed ID: 2615299
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of Levamisole on peripheral blood lymphocyte subpopulations in patients with rheumatoid arthritis and ankylosing spondylitis.
    Rosenthal M; Trabert U; Müller W
    Clin Exp Immunol; 1976 Sep; 25(3):493-6. PubMed ID: 1085681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A combination of immunostimulants as a method for correcting secondary immunodeficiencies].
    Alekhin EK; Lazareva DN; Bogdanova ASh; Riabchinskaia LA; Mufazalova NA; Khasanova DD
    Eksp Klin Farmakol; 1993; 56(2):39-42. PubMed ID: 8348038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.